Previous studies have suggested that the inactivation of ARF (p14) through epigenetic silencing plays an important deregulating mechanism of the ARF-MDM2-p53 pathways, leading to a restriction of the tumor-suppressing activity of p53 [91]. This evidence concerns the gene CDKN2A and neoplasm.